Key result
The management of oral anticoagulation during elective procedures requires an individualized approach based on the procedural bleeding risk and the patient's thromboembolic and hemorrhagic risk.
Why the study?
With a growing number of patients and medications, the aim was to review the management of anticoagulated patients undergoing elective surgery or invasive procedures.
Management of oral anticoagulation during elective surgery requires individualized assessment of procedural bleeding risk and patient thromboembolic risk to determine the optimal strategy.
Supports individualized periprocedural OAC decisions; leaves open prospective validation of risk tools.
Oral anticoagulants play a key role in prevention and treatment of cardiovascular diseases. In the last years, the number of patients taking oral anticoagulants is growing and we have more medicaments in use. The aim of this review is to study the management of anticoagulated patients, undergoing elective surgery or invasive procedures. The scientific information for this review is taken from PubMed. The decision about the oral anticoagulation depends of the bleeding risk, associated with the procedure, of the individual thromboembolic and bleeding risk. After the evaluation, the proper strategy is chosen, which could be temporary interruption, bridging with parenteral anticoagulant or continuing therapy. We have algorithms, but individual approach and multidisciplinary care is needed.
No takes yet. Share an insight, caveat, or question.
Kisheva et al. (2020) conducted a review in Patients on oral anticoagulants undergoing elective surgery or invasive procedures. Perioperative management of oral anticoagulation was evaluated. The management of oral anticoagulation during elective procedures requires an individualized approach based on the procedural bleeding risk and the patient's thromboembolic and hemorrhagic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: